Recent studies have focused on the intersection of GLP|GIP|GCGR activator therapies and DA communication. While GLP agonists are widely employed for addressing type 2 diabetes mellitus, their unexpected consequences on reinforcement circuits, specifically influenced by DA systems, are attracting significant interest. This report provides a conci… Read More